Impact of the COVID-19 breast cancer screening hiatus on clinical stage and racial disparities in New York City
Recommended Citation
Fasano GA, Bayard S, Tamimi R, Bea V, Malik M, Davis M, Simmons R, Swistel A, Marti J, Drotman M, Katzen J, Formenti S, Ng J, Astrow A, Taiwo E, Balogun O, Siegel B, Radzio A, Elreda L, Chen Y, and Newman L. Impact of the COVID-19 breast cancer screening hiatus on clinical stage and racial disparities in New York City. Am J Surg 2022.
Document Type
Article
Publication Date
5-27-2022
Publication Title
American journal of surgery
Abstract
BACKGROUND: The impact of the COVID-19 mammography screening hiatus as well as of post-hiatus efforts promoting restoration of elective healthcare on breast cancer detection patterns and stage distribution is unknown.
METHODS: Newly diagnosed breast cancer patients (2019-2021) at the New York Presbyterian (NYP) Hospital Network were analyzed. Chi-square and student's t-test compared characteristics of patients presenting before and after the screening hiatus.
RESULTS: A total of 2137 patients were analyzed. Frequency of screen-detected and early-stage breast cancer declined post-hiatus (59.7%), but returned to baseline (69.3%). Frequency of screen-detected breast cancer was lowest for African American (AA) (57.5%) and Medicaid patients pre-hiatus (57.2%), and this disparity was reduced post-hiatus (65.3% for AA and 63.2% for Medicaid).
CONCLUSIONS: The return to baseline levels of screen-detected cancer, particularly among AA and Medicaid patients suggest that large-scale breast health education campaigns may be effective in resuming screening practices and in mitigating disparities.
PubMed ID
35641320
ePublication
ePub ahead of print
